- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03843866
Sutures Versus Glue in Laparoscopic Port Site Closure. (STILS)
The Use of Absorbable Suture Versus Tissue Glue in Laparoscopic Port Skin Closure. A Prospective, Randomised Control Trial. The STILS Trial.
Cosmesis postoperatively is an important consideration for both patients and surgeons and consequently surgeons have become increasingly interested in replacing conventional sutures by means of adhesive bonds for the closure of skin wounds.
Therefore the investigators are using two different close techniques for laparoscopic wounds. These are; 1. sutures with steri-strips and 2. adhesive bond.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dublin, Ireland
- St. James Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Elective Laparoscopic surgeries. Emergency Laparoscopic surgeries.
Exclusion Criteria:
- Contaminated wounds. immunocompromised patients. diabetic patients. history of Keloid scarring.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Suture & steri-strips
|
sutures and steri-strips
Other Names:
|
Active Comparator: Adhesive Glue
|
Adhesive Glue
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cosmesis
Time Frame: 6 months
|
Cosmetic outcome being graded by patient and clinician via questionnaire.
Observer scar assessment form (1-10) 1 = worst result possible, 10 being the best result possible.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgical site infection (SSI).
Time Frame: 6 months
|
Any superficial site infection which requires antibiotic use or wound complication such as dehisence.
This information will be obtained from clinic.
|
6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SJH 2019-1.0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infection
-
West Virginia UniversityEnrolling by invitationSkin and Soft Tissue Infection | Gastrointestinal Infection | Pulmonary Infection | Bone and Joint Infection | Endovascular Infection | Genitourinary InfectionUnited States
-
Ondine Biomedical Inc.CompletedSurgical Site Infection | Nosocomial Infection | Healthcare Associated InfectionUnited States
-
Gundersen Lutheran Medical FoundationGundersen Lutheran Health SystemCompletedSurgical Site Infection | Superficial Surgical Site Infection | Deep Surgical Site Infection | Organ/Space Surgical Site InfectionUnited States
-
Croydon Health Services NHS TrustCompletedSurgical Site Infection | Wound Infection | Cesarean Section; Infection | Perineal InfectionUnited Kingdom
-
Cairo UniversityRecruitingPostoperative Infection | Cesarean Section Complications | Vaginal InfectionEgypt
-
Leiden University Medical CenterRadboud University Medical Center; University Medical Center Groningen; Erasmus... and other collaboratorsRecruitingProsthetic-joint Infection | Infection Hip | Infection; Knee, JointNetherlands
-
Vastra Gotaland RegionGöteborg UniversityRecruitingProsthetic Joint Infection | Hip Prosthesis Infection | Prosthetic Infection | Knee Prosthesis InfectionSweden
-
University of ZurichCompletedProsthetic Joint Infection | Surgical Site Infection | Prosthesis and Implants | Postoperative Wound Infection Deep Incisional Surgical SiteSwitzerland
-
University of ZurichCompletedProsthetic Joint Infection | Surgical Site Infection | Prosthesis and Implants | Postoperative Wound Infection Deep Incisional Surgical SiteSwitzerland
-
University of ZurichRecruitingProsthetic Joint Infection | Surgical Site Infection | Prosthesis and Implants | Postoperative Wound Infection Deep Incisional Surgical SiteSwitzerland
Clinical Trials on 4-0 Monocryl
-
Washington University School of MedicineCompletedWound Infection | Wound ComplicationUnited States
-
Foundation for Southwest Orthopedic ResearchCompletedWound Closure | Total Knee Replacement ClosureUnited States
-
Instituto de Investigación Hospital Universitario...Surgical Infection Society EuropeUnknownColorectal Surgery | Surgical Wound InfectionsSpain
-
University of Alabama at BirminghamTerminated
-
MemorialCare Health SystemUniversity of California, IrvineCompletedCesarean Section | Obesity, SevereUnited States
-
University of British ColumbiaBC Children's Hospital Research InstituteUnknownPostoperative Complications | Chorioamnionitis | Pregnancy Complications, Infectious | Complications; Cesarean SectionCanada
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
Medtronic - MITGCompletedObesity | Breast PtosisUnited States, Germany
-
Sun Yat-sen UniversityCompletedSurgery--Complications | Retinoblastoma Bilateral
-
Amsterdam UMC, location VUmcCompleted